Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis GENE

Max Ratio

Dividend Yield

5Y Dividend Growth

0.00 %

Consecutive Years

5Y Average Payout Ratio

Dividend History GENE

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield
Consecutive Years 0
Forward Annual Dividend – USD
Consistent Years 0
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth GENE

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin GENE

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income GENE

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM GENE

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio GENE

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Genetic Technologies Ltd GENE

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Itself GENE

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.070
Price Sales TTM 0.38
Enterprise Value EBITDA -2.44
Price Book MRQ 3.29

Genetic Technologies Ltd Dividends: Yield, History, Payment Schedule

GENE
Current price
1 933.80 USD 0 USD (0.00%)
Last closed 1 920.80 USD
ISIN US37185R3075
Sector Healthcare
Industry Diagnostics & Research
Exchange NASDAQ
Capitalization 3 708 138 USD
Yield for 12 month +0.65 %
1Y
3Y
5Y
10Y
15Y
GENE
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+5 499 594 USD

Last Year

+7 424 773 USD

Current Quarter

+3 443 906 USD

Last Quarter

+1 721 953 USD

Current Year

+2 801 517 USD

Last Year

+4 314 157 USD

Current Quarter

+2 006 095 USD

Last Quarter

+1 003 048 USD
EBITDA -10 356 715 USD
Operating Margin TTM -113.14 %
Price to Earnings
Return On Assets TTM -62.93 %
PEG Ratio
Return On Equity TTM -184.98 %
Wall Street Target Price 12.50 USD
Revenue TTM 9 672 800 USD
Book Value 0.014 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -10.60 %
Dividend Yield
Gross Profit TTM 5 912 490 USD
Earnings per share -0.020 USD
Diluted Eps TTM -0.020 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -124.24 %
Price to Free Cash Flow TTM

Technical Indicators GENE

For 52 Weeks

1 492.40 USD 1 943.90 USD
50 Day MA 0.77 USD
Shares Short Prior Month 25 845
200 Day MA 1.10 USD
Short Ratio 15.67
Shares Short 25 845
Short Percent 0.56 %